Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The first human tissue samples from Oxford's Space Innovation Lab (SIL) have been launched and are on their way to the International Space Station, where they will be used to study the effects of space microgravity on the human ageing process.

International Space Station © Getty Images (dima_zel)

Researchers from the SIL flew to the Kennedy Space Centre (Florida, USA) to integrate the samples into the payload in preparation for the launch, which took place early in the early hours of Tuesday 5th November (UK time).

The samples are housed inside a Science Cube, which will be accommodated inside the ICE Cubes Facility once onboard the ISS; the platform provides power and data to the payload, as well as real-time connectivity with ground, enabling researchers back in Oxford to monitor and interact with the experiment in real-time.

Dr Ghada Alsaleh, who leads the Space Innovation Lab at Oxford, said: 'This is an exciting moment— not just because we're embarking on a journey to space, but because we're bringing along a ground-breaking project that could help people live healthier lives, both on Earth and in Space.

'Our project seeks to uncover how ageing progresses under microgravity conditions, and to test if these conditions could speed up the study of ageing processes that take much longer to observe on Earth. By conducting this research on the International Space Station (ISS), we hope to gain insights that could lead to breakthroughs in understanding and treating age-related diseases. These discoveries could significantly improve the quality of life for people on Earth, reducing the burden of ageing not only for individuals but also for their loved ones and society as a whole.

 

Read the full story on the University of Oxford website.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience